{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:24:30Z","timestamp":1792790670401,"version":"4.5.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MSH Medical School Hamburg","id":[{"id":"https:\/\/ror.org\/006thab72","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MBExC and SFB1286 (B6 and B8)"],"award-info":[{"award-number":["MBExC and SFB1286 (B6 and B8)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s Disease (PD) is a prevalent neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra. This leads to hallmark motor features that include bradykinesia, resting tremor, rigidity, and postural instability, alongside with a range of non-motor symptoms including sleep disturbances, mood disorders, and cognitive decline. As global life expectancy rises, the prevalence of PD is expected to continue to increase, highlighting the urgent need for effective therapeutic strategies. Despite tremendous advances in our understanding of disease-associated mechanisms, we still do not fully understand the aetiology of PD. Emerging evidence points to the circadian clock\u2014a system that regulates physiological processes such as sleep-wake cycles and hormone release\u2014as a critical factor in PD pathophysiology. Disruptions in circadian rhythms (CR) are common in PD patients and may exacerbate both motor and non-motor symptoms, potentially influencing the progression of neurodegeneration. This review examines the global impact of PD within the context of an aging population, delves into the molecular underpinnings of the disease, and explores the role of CR in PD. We summarize and discuss key reports on molecular links between PD and CR using unbiased systematic search strategies to cover a broad literature. Finally, we discuss the potential of chronotherapy, the alignment of treatment with the body\u2019s natural rhythms, as a personalized approach in PD management, aiming to improve treatment efficacy and patient quality of life. Understanding the interplay between circadian biology and PD could pave the way for innovative, personalized therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41531-025-01009-9","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:41:14Z","timestamp":1752507674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Circadian clock dysfunction in Parkinson\u2019s disease: mechanisms, consequences, and therapeutic strategy"],"prefix":"10.1038","volume":"11","author":[{"given":"M\u00fcge","family":"Yal\u00e7in","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Fleming","family":"Outeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rel\u00f3gio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"1009_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of Parkinson\u2019s disease. Lancet 403, 283\u2013292 (2024).","journal-title":"Lancet"},{"key":"1009_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000531422","volume":"32","author":"EKJ Pauwels","year":"2023","unstructured":"Pauwels, E. K. J. & Boer, G. J. Parkinson\u2019s disease: a tale of many players. Med Princ. Pr. 32, 155\u2013165 (2023).","journal-title":"Med Princ. Pr."},{"key":"1009_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1009_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang, W. et al. Current and projected future economic burden of Parkinson\u2019s disease in the U.S. NPJ Parkinsons Dis. 6, 15 (2020).","journal-title":"NPJ Parkinsons Dis."},{"key":"1009_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","volume":"10","author":"LY Ma","year":"2019","unstructured":"Ma, L. Y. et al. Alpha-synuclein in peripheral tissues in Parkinson\u2019s disease. ACS Chem. Neurosci. 10, 812\u2013823 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"1009_CR6","doi-asserted-by":"publisher","first-page":"106078","DOI":"10.1016\/j.parkreldis.2024.106078","volume":"122","author":"A Chopra","year":"2024","unstructured":"Chopra, A., Lang, A. E., H\u00f6glinger, G. & Outeiro, T. F. Towards a biological diagnosis of PD. Parkinsonism Relat. Disord. 122, 106078 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1009_CR7","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005\u2013d1012 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1009_CR8","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/brain\/awae188","volume":"147","author":"A Westenberger","year":"2024","unstructured":"Westenberger, A. et al. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson\u2019s disease study. Brain 147, 2652\u20132667 (2024).","journal-title":"Brain"},{"key":"1009_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/10937404.2019.1659197","volume":"22","author":"C Vaccari","year":"2019","unstructured":"Vaccari, C., El Dib, R., Gomaa, H., Lopes, L. C. & de Camargo, J. L. Paraquat and Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. J. Toxicol. Environ. Health B Crit. Rev. 22, 172\u2013202 (2019).","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"1009_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-8-6","volume":"8","author":"DB Hancock","year":"2008","unstructured":"Hancock, D. B. et al. Pesticide exposure and risk of Parkinson\u2019s disease: a family-based case-control study. BMC Neurol. 8, 6 (2008).","journal-title":"BMC Neurol."},{"key":"1009_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-319-60189-2_7","volume":"18","author":"WM Caudle","year":"2017","unstructured":"Caudle, W. M. Occupational metal exposure and parkinsonism. Adv. Neurobiol. 18, 143\u2013158 (2017).","journal-title":"Adv. Neurobiol."},{"key":"1009_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/JOM.0000000000001634","volume":"61","author":"SR Criswell","year":"2019","unstructured":"Criswell, S. R. et al. MRI Signal intensity and parkinsonism in manganese-exposed workers. J. Occup. Environ. Med. 61, 641\u2013645 (2019).","journal-title":"J. Occup. Environ. Med."},{"key":"1009_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. The pathogenesis of Parkinson\u2019s disease. Lancet 403, 293\u2013304 (2024).","journal-title":"Lancet"},{"key":"1009_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/mds.26509","volume":"31","author":"A Videnovic","year":"2016","unstructured":"Videnovic, A. & Willis, G. L. Circadian system \u2014 A novel diagnostic and therapeutic target in Parkinson\u2019s disease?. Mov. Disord. 31, 260\u2013269 (2016).","journal-title":"Mov. Disord."},{"key":"1009_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41582-021-00577-7","volume":"18","author":"M Nassan","year":"2022","unstructured":"Nassan, M. & Videnovic, A. Circadian rhythms in neurodegenerative disorders. Nat. Rev. Neurol. 18, 7\u201324 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"1009_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/joim.13541","volume":"292","author":"M Hariz","year":"2022","unstructured":"Hariz, M. & Blomstedt, P. Deep brain stimulation for Parkinson\u2019s disease. J. Intern. Med. 292, 764\u2013778 (2022).","journal-title":"J. Intern. Med."},{"key":"1009_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/hr.2015.142","volume":"39","author":"RC Hermida","year":"2016","unstructured":"Hermida, R. C. et al. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens. Res. 39, 277\u2013292 (2016).","journal-title":"Hypertens. Res."},{"key":"1009_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s41030-018-0058-6","volume":"4","author":"K Krakowiak","year":"2018","unstructured":"Krakowiak, K. & Durrington, H. J. The role of the body clock in asthma and COPD: implication for treatment. Pulm. Ther. 4, 29\u201343 (2018).","journal-title":"Pulm. Ther."},{"key":"1009_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64645-6","volume":"10","author":"T Endo","year":"2020","unstructured":"Endo, T. et al. Bright light improves sleep in patients with Parkinson\u2019s disease: possible role of circadian restoration. Sci. Rep. 10, 7982 (2020).","journal-title":"Sci. Rep."},{"key":"1009_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/annurev-physiol-021909-135821","volume":"72","author":"C Dibner","year":"2010","unstructured":"Dibner, C., Schibler, U. & Albrecht, U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 72, 517\u2013549 (2010).","journal-title":"Annu. Rev. Physiol."},{"key":"1009_CR21","doi-asserted-by":"publisher","first-page":"873237","DOI":"10.3389\/fphys.2022.873237","volume":"13","author":"M Yal\u00e7in","year":"2022","unstructured":"Yal\u00e7in, M. et al. It\u2019s about time: the circadian network as time-keeper for cognitive functioning, locomotor activity and mental health. Front. Physiol. 13, 873237 (2022).","journal-title":"Front. Physiol."},{"key":"1009_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-022-00899-y","volume":"7","author":"F Fagiani","year":"2022","unstructured":"Fagiani, F. et al. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct. Target Ther. 7, 41 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"1009_CR23","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1128\/MCB.00338-09","volume":"29","author":"JP Etchegaray","year":"2009","unstructured":"Etchegaray, J. P. et al. Casein kinase 1 delta regulates the pace of the mammalian circadian clock. Mol. Cell Biol. 29, 3853\u20133866 (2009).","journal-title":"Mol. Cell Biol."},{"key":"1009_CR24","first-page":"225","volume":"10","author":"F Halberg","year":"1959","unstructured":"Halberg, F. [Physiologic 24-hour periodicity; general and procedural considerations with reference to the adrenal cycle]. Int Z. Vitaminforsch Beih. 10, 225\u2013296 (1959).","journal-title":"Int Z. Vitaminforsch Beih."},{"key":"1009_CR25","doi-asserted-by":"crossref","unstructured":"Guan, D. & Lazar, M. A. Interconnections between circadian clocks and metabolism. J. Clin. Invest. 131, e148278 (2021).","DOI":"10.1172\/JCI148278"},{"key":"1009_CR26","doi-asserted-by":"crossref","unstructured":"Palomino-Segura, M. & Hidalgo, A. Circadian immune circuits. J. Exp. Med. 218, e20200798 (2020).","DOI":"10.1084\/jem.20200798"},{"key":"1009_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.tcb.2018.01.006","volume":"28","author":"J Gaucher","year":"2018","unstructured":"Gaucher, J., Montellier, E. & Sassone-Corsi, P. Molecular cogs: interplay between circadian clock and cell cycle. Trends Cell Biol. 28, 368\u2013379 (2018).","journal-title":"Trends Cell Biol."},{"key":"1009_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.add0846","volume":"379","author":"L Talamanca","year":"2023","unstructured":"Talamanca, L., Gobet, C. & Naef, F. Sex-dimorphic and age-dependent organization of 24-hour gene expression rhythms in humans. Science 379, 478\u2013483 (2023).","journal-title":"Science"},{"key":"1009_CR29","doi-asserted-by":"crossref","unstructured":"Mure, L. S. et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science 359, eaao0318 (2018).","DOI":"10.1126\/science.aao0318"},{"key":"1009_CR30","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1073\/pnas.1408886111","volume":"111","author":"R Zhang","year":"2014","unstructured":"Zhang, R., Lahens, N. F., Ballance, H. I., Hughes, M. E. & Hogenesch, J. B. A circadian gene expression atlas in mammals: Implications for biology and medicine. Proc. Natl Acad. Sci. USA 111, 16219\u201316224 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1009_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3988\/jcn.2022.18.2.140","volume":"18","author":"H Kim","year":"2022","unstructured":"Kim, H., Jung, H. R., Kim, J. B. & Kim, D.-J. Autonomic dysfunction in sleep disorders: from neurobiological basis to potential therapeutic approaches. J. Clin. Neurol. 18, 140\u2013151 (2022).","journal-title":"J. Clin. Neurol."},{"key":"1009_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/mds.27268","volume":"33","author":"A Merola","year":"2018","unstructured":"Merola, A. et al. Autonomic dysfunction in Parkinson\u2019s disease: A prospective cohort study. Mov. Disord. 33, 391\u2013397 (2018).","journal-title":"Mov. Disord."},{"key":"1009_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.06.032","volume":"56","author":"V Milazzo","year":"2018","unstructured":"Milazzo, V. et al. Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease. Parkinsonism Relat. Disord. 56, 82\u201387 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1009_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5603\/pjnns.96939","volume":"58","author":"JJ Malkiewicz","year":"2024","unstructured":"Malkiewicz, J. J. & Siuda, J. Comparison of autonomic dysfunction in patients with Parkinson\u2019s disease, progressive supranuclear palsy, and multiple system atrophy. Neurol. Neurochir. Pol. 58, 193\u2013202 (2024).","journal-title":"Neurol. Neurochir. Pol."},{"key":"1009_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/B978-0-444-64074-1.00043-4","volume":"157","author":"EA Coon","year":"2018","unstructured":"Coon, E. A. & Low, P. A. Thermoregulation in Parkinson disease. Handb. Clin. Neurol. 157, 715\u2013725 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"1009_CR37","doi-asserted-by":"crossref","unstructured":"Tulb\u0103, D. et al. Blood pressure patterns in patients with Parkinson\u2019s disease: a systematic review. J. Pers. Med. 11, 129 (2021).","DOI":"10.3390\/jpm11020129"},{"key":"1009_CR38","doi-asserted-by":"crossref","unstructured":"Thangaleela, S. et al. Neurological insights into sleep disorders in Parkinson\u2019s disease. Brain Sci. 13, 1202 (2023).","DOI":"10.3390\/brainsci13081202"},{"key":"1009_CR39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41582-019-0241-x","volume":"15","author":"H Wood","year":"2019","unstructured":"Wood, H. New models show gut\u2013brain transmission of Parkinson disease pathology. Nat. Rev. Neurol. 15, 491\u2013491 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"1009_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103, 627\u2013641.e627 (2019).","journal-title":"Neuron"},{"key":"1009_CR41","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel, S. et al. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. 34, 1464\u20131470 (2019).","journal-title":"Mov. Disord."},{"key":"1009_CR42","doi-asserted-by":"publisher","first-page":"e209699","DOI":"10.1212\/WNL.0000000000209699","volume":"103","author":"J Gallagher","year":"2024","unstructured":"Gallagher, J. et al. Long-term dementia risk in Parkinson disease. Neurology 103, e209699 (2024).","journal-title":"Neurology"},{"key":"1009_CR43","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamaneurol.2018.0640","volume":"75","author":"E De Pablo-Fern\u00e1ndez","year":"2018","unstructured":"De Pablo-Fern\u00e1ndez, E., Courtney, R., Warner, T. T. & Holton, J. L. A Histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy. JAMA Neurol. 75, 1008\u20131012 (2018).","journal-title":"JAMA Neurol."},{"key":"1009_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s40675-017-0079-y","volume":"3","author":"P Gros","year":"2017","unstructured":"Gros, P. & Videnovic, A. Sleep and circadian rhythm disorders in Parkinson's disease. Curr. Sleep. Med. Rep. 3, 222\u2013234 (2017).","journal-title":"Curr. Sleep. Med. Rep."},{"key":"1009_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/mds.26509","volume":"31","author":"A Videnovic","year":"2016","unstructured":"Videnovic, A. & Willis, G. L. Circadian system - a novel diagnostic and therapeutic target in Parkinson\u2019s disease?. Mov. Disord. 31, 260\u2013269 (2016).","journal-title":"Mov. Disord."},{"key":"1009_CR46","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mds.22057","volume":"23","author":"DL Whitehead","year":"2008","unstructured":"Whitehead, D. L., Davies, A. D., Playfer, J. R. & Turnbull, C. J. Circadian rest-activity rhythm is altered in Parkinson\u2019s disease patients with hallucinations. Mov. Disord. 23, 1137\u20131145 (2008).","journal-title":"Mov. Disord."},{"key":"1009_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1600-0404.1993.tb04096.x","volume":"87","author":"JJ van Hilten","year":"1993","unstructured":"van Hilten, J. J. et al. Assessment of response fluctuations in Parkinson\u2019s disease by ambulatory wrist activity monitoring. Acta Neurol. Scand. 87, 171\u2013177 (1993).","journal-title":"Acta Neurol. Scand."},{"key":"1009_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.sleep.2021.06.023","volume":"85","author":"K Obayashi","year":"2021","unstructured":"Obayashi, K. et al. Circadian activity rhythm in Parkinson\u2019s disease: findings from the PHASE study. Sleep. Med. 85, 8\u201314 (2021).","journal-title":"Sleep. Med."},{"key":"1009_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/07420528.2020.1715998","volume":"37","author":"C Brooks","year":"2020","unstructured":"Brooks, C. et al. Variations in rest-activity rhythm are associated with clinically measured disease severity in Parkinson\u2019s disease. Chronobiol. Int. 37, 699\u2013711 (2020).","journal-title":"Chronobiol. Int."},{"key":"1009_CR50","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/ana.25853","volume":"88","author":"H Feng","year":"2020","unstructured":"Feng, H. et al. Rest-activity pattern alterations in idiopathic REM sleep behavior disorder. Ann. Neurol. 88, 817\u2013829 (2020).","journal-title":"Ann. Neurol."},{"key":"1009_CR51","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jamaneurol.2020.1623","volume":"77","author":"Y Leng","year":"2020","unstructured":"Leng, Y. et al. Association of circadian abnormalities in older adults with an increased risk of developing Parkinson disease. JAMA Neurol. 77, 1270\u20131278 (2020).","journal-title":"JAMA Neurol."},{"key":"1009_CR52","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/mdc3.12692","volume":"5","author":"JQ Wu","year":"2018","unstructured":"Wu, J. Q., Li, P., Stavitsky Gilbert, K., Hu, K. & Cronin-Golomb, A. Circadian rest-activity rhythms predict cognitive function in early Parkinson\u2019s disease independently of sleep. Mov. Disord. Clin. Pr. 5, 614\u2013619 (2018).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1009_CR53","doi-asserted-by":"publisher","first-page":"e12939","DOI":"10.1111\/jsr.12939","volume":"29","author":"AK Raupach","year":"2020","unstructured":"Raupach, A. K. et al. Assessing the role of nocturnal core body temperature dysregulation as a biomarker of neurodegeneration. J. Sleep. Res. 29, e12939 (2020).","journal-title":"J. Sleep. Res."},{"key":"1009_CR54","doi-asserted-by":"publisher","first-page":"e72661","DOI":"10.1371\/journal.pone.0072661","volume":"8","author":"G Zhong","year":"2013","unstructured":"Zhong, G., Bolitho, S., Grunstein, R., Naismith, S. L. & Lewis, S. J. The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson\u2019s disease. PLoS ONE 8, e72661 (2013).","journal-title":"PLoS ONE"},{"key":"1009_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","volume":"71","author":"DP Breen","year":"2014","unstructured":"Breen, D. P. et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 71, 589\u2013595 (2014).","journal-title":"JAMA Neurol."},{"key":"1009_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00702-018-1947-4","volume":"126","author":"NM Soares","year":"2019","unstructured":"Soares, N. M., Pereira, G. M., Altmann, V., de Almeida, R. M. M. & Rieder, C. R. M. Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson\u2019s disease: a systematic review. J. Neural Transm.126, 219\u2013232 (2019).","journal-title":"J. Neural Transm."},{"key":"1009_CR57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","volume":"71","author":"A Videnovic","year":"2014","unstructured":"Videnovic, A. et al. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 71, 463\u2013469 (2014).","journal-title":"JAMA Neurol."},{"key":"1009_CR58","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.sleep.2013.10.016","volume":"15","author":"SJ Bolitho","year":"2014","unstructured":"Bolitho, S. J. et al. Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease. Sleep. Med. 15, 342\u2013347 (2014).","journal-title":"Sleep. Med."},{"key":"1009_CR59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000119735","volume":"56","author":"K Suzuki","year":"2007","unstructured":"Suzuki, K. et al. Circadian variation of core body temperature in Parkinson disease patients with depression: a potential biological marker for depression in Parkinson disease. Neuropsychobiology 56, 172\u2013179 (2007).","journal-title":"Neuropsychobiology"},{"key":"1009_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep15891","volume":"5","author":"Z Gu","year":"2015","unstructured":"Gu, Z. et al. Association of ARNTL and PER1 genes with Parkinson\u2019s disease: a case-control study of Han Chinese. Sci. Rep. 5, 15891 (2015).","journal-title":"Sci. Rep."},{"key":"1009_CR61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s12264-017-0167-5","volume":"33","author":"F Lou","year":"2017","unstructured":"Lou, F. et al. CLOCK rs1801260 polymorphism is associated with susceptibility to Parkinson\u2019s disease in a Chinese population. Neurosci. Bull. 33, 734\u2013736 (2017).","journal-title":"Neurosci. Bull."},{"key":"1009_CR62","first-page":"4670380","volume":"2018","author":"F Lou","year":"2018","unstructured":"Lou, F., Li, M., Luo, X. & Ren, Y. CLOCK 3111T\/C variant correlates with motor fluctuation and sleep disorders in Chinese patients with Parkinson\u2019s disease. Parkinsons Dis. 2018, 4670380 (2018).","journal-title":"Parkinsons Dis."},{"key":"1009_CR63","doi-asserted-by":"publisher","first-page":"101554","DOI":"10.1016\/j.arr.2021.101554","volume":"74","author":"AD Shkodina","year":"2022","unstructured":"Shkodina, A. D. et al. Roles of clock genes in the pathogenesis of Parkinson\u2019s disease. Ageing Res. Rev. 74, 101554 (2022).","journal-title":"Ageing Res. Rev."},{"key":"1009_CR64","unstructured":"Jacobi, D., Atger, F. & Lee, C.-H. in Circadian Rhythms and Their Impact on Aging (eds Jazwinski, S. M., Belancio, V. P., & Hill, S. M.) (Springer International Publishing, 2017)."},{"key":"1009_CR65","doi-asserted-by":"crossref","unstructured":"Pacelli, C. et al. Parkin mutation affects clock gene-dependent energy metabolism. Int. J. Mol. Sci. 20, 2772 (2019).","DOI":"10.3390\/ijms20112772"},{"key":"1009_CR66","doi-asserted-by":"publisher","first-page":"4854732","DOI":"10.1155\/2018\/4854732","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Disruption of the circadian clock alters antioxidative defense via the SIRT1-BMAL1 pathway in 6-OHDA-induced models of Parkinson\u2019s disease. Oxid. Med. Cell Longev. 2018, 4854732 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1009_CR67","doi-asserted-by":"publisher","first-page":"736026","DOI":"10.3389\/fnagi.2021.736026","volume":"13","author":"T Li","year":"2021","unstructured":"Li, T. et al. Peripheral clock system abnormalities in patients with Parkinson\u2019s disease. Front. Aging Neurosci. 13, 736026 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1009_CR68","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1468-1331.2009.02848.x","volume":"17","author":"Y Cai","year":"2010","unstructured":"Cai, Y., Liu, S., Sothern, R. B., Xu, S. & Chan, P. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson\u2019s disease. Eur. J. Neurol. 17, 550\u2013554 (2010).","journal-title":"Eur. J. Neurol."},{"key":"1009_CR69","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neulet.2011.05.058","volume":"499","author":"H Ding","year":"2011","unstructured":"Ding, H. et al. Decreased expression of Bmal2 in patients with Parkinson\u2019s disease. Neurosci. Lett. 499, 186\u2013188 (2011).","journal-title":"Neurosci. Lett."},{"key":"1009_CR70","doi-asserted-by":"crossref","unstructured":"Yalcin, M. et al. A computational analysis in a cohort of Parkinson\u2019s disease patients and clock-modified colorectal cancer cells reveals common expression alterations in clock-regulated genes. Cancers 13, 5978 (2021).","DOI":"10.3390\/cancers13235978"},{"key":"1009_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S. & Li-Hua, P. Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct. Target Ther. 8, 73 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"1009_CR72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.conb.2021.09.001","volume":"72","author":"E Nachman","year":"2022","unstructured":"Nachman, E. & Verstreken, P. Synaptic proteostasis in Parkinson\u2019s disease. Curr. Opin. Neurobiol. 72, 72\u201379 (2022).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1009_CR73","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.18632\/aging.101691","volume":"10","author":"T Hentrich","year":"2018","unstructured":"Hentrich, T., Wassouf, Z., Riess, O. & Schulze-Hentrich, J. M. SNCA overexpression disturbs hippocampal gene expression trajectories in midlife. Aging 10, 4024\u20134041 (2018).","journal-title":"Aging"},{"key":"1009_CR74","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s12264-022-00881-2","volume":"38","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Altered motor performance, sleep EEG, and Parkinson\u2019s disease pathology induced by chronic sleep deprivation in Lrrk2(G2019S) mice. Neurosci. Bull. 38, 1170\u20131182 (2022).","journal-title":"Neurosci. Bull."},{"key":"1009_CR75","doi-asserted-by":"crossref","unstructured":"Verma, D. K. et al. Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson\u2019s disease models. Cells 10, 1694 (2021).","DOI":"10.3390\/cells10071694"},{"key":"1009_CR76","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-024-01816-8","volume":"10","author":"B Hong","year":"2024","unstructured":"Hong, B., Ohtake, Y., Itokazu, T. & Yamashita, T. Glial senescence enhances \u03b1-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction. Cell Death Discov. 10, 50 (2024).","journal-title":"Cell Death Discov."},{"key":"1009_CR77","doi-asserted-by":"publisher","first-page":"e0131281","DOI":"10.1371\/journal.pone.0131281","volume":"10","author":"L-K Song","year":"2015","unstructured":"Song, L.-K. et al. Targeted overexpression of \u03b1-synuclein by rAAV2\/1 vectors induces progressive nigrostriatal degeneration and increases vulnerability to MPTP in mouse. PLoS ONE 10, e0131281 (2015).","journal-title":"PLoS ONE"},{"key":"1009_CR78","doi-asserted-by":"crossref","unstructured":"Chakrabarti, S. & Bisaglia, M. Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products. Antioxidants 12, 955 (2023).","DOI":"10.3390\/antiox12040955"},{"key":"1009_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-019-0506-8","volume":"20","author":"B Dokt\u00f3r","year":"2019","unstructured":"Dokt\u00f3r, B., Damulewicz, M. & Pyza, E. Effects of MUL1 and PARKIN on the circadian clock, brain and behaviour in Drosophila Parkinson\u2019s disease models. BMC Neurosci. 20, 24 (2019).","journal-title":"BMC Neurosci."},{"key":"1009_CR80","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/tra.12866","volume":"23","author":"L Wang","year":"2022","unstructured":"Wang, L., Wang, H., Yi, S., Zhang, S. & Ho, M. S. A LRRK2\/dLRRK-mediated lysosomal pathway that contributes to glial cell death and DA neuron survival. Traffic 23, 506\u2013520 (2022).","journal-title":"Traffic"},{"key":"1009_CR81","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","volume":"69","author":"ZI Alam","year":"1997","unstructured":"Alam, Z. I. et al. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69, 1196\u20131203 (1997).","journal-title":"J. Neurochem."},{"key":"1009_CR82","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva, I. et al. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum. Mol. Genet. 26, 2231\u20132246 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"1009_CR83","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.abb.2006.02.018","volume":"449","author":"ML Hegde","year":"2006","unstructured":"Hegde, M. L. et al. Studies on genomic DNA topology and stability in brain regions of Parkinson\u2019s disease. Arch. Biochem. Biophys. 449, 143\u2013156 (2006).","journal-title":"Arch. Biochem. Biophys."},{"key":"1009_CR84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-3-319-53889-1_19","volume":"978","author":"MAS Pavlou","year":"2017","unstructured":"Pavlou, M. A. S. & Outeiro, T. F. Epigenetics in Parkinson\u2019s disease. Adv. Exp. Med. Biol. 978, 363\u2013390 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1009_CR85","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-016-1590-9","volume":"132","author":"C Labb\u00e9","year":"2016","unstructured":"Labb\u00e9, C., Lorenzo-Betancor, O. & Ross, O. A. Epigenetic regulation in Parkinson\u2019s disease. Acta Neuropathol. 132, 515\u2013530 (2016).","journal-title":"Acta Neuropathol."},{"key":"1009_CR86","doi-asserted-by":"crossref","unstructured":"Leggio, L. et al. microRNAs in Parkinson\u2019s disease: from pathogenesis to novel diagnostic and therapeutic approaches. Int. J. Mol. Sci. 18, 2698 (2017).","DOI":"10.3390\/ijms18122698"},{"key":"1009_CR87","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JPD-230457","volume":"14","author":"JT Gionco","year":"2024","unstructured":"Gionco, J. T. & Bernstein, A. I. Emerging role of environmental epitranscriptomics and RNA modifications in Parkinson\u2019s disease. J. Parkinsons Dis. 14, 643\u2013656 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1009_CR88","doi-asserted-by":"publisher","first-page":"8567","DOI":"10.1111\/jcmm.16740","volume":"25","author":"Y Teng","year":"2021","unstructured":"Teng, Y. et al. Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function. J. Cell Mol. Med. 25, 8567\u20138572 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"1009_CR89","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1021\/acschemneuro.8b00657","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Down-regulation of m6A mRNA methylation is involved in dopaminergic neuronal death. ACS Chem. Neurosci. 10, 2355\u20132363 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"1009_CR90","doi-asserted-by":"publisher","first-page":"e12885","DOI":"10.1111\/nan.12885","volume":"49","author":"B Martinez De La Cruz","year":"2023","unstructured":"Martinez De La Cruz, B. et al. m(6) A mRNA methylation in human brain is disrupted in Lewy body disorders. Neuropathol. Appl. Neurobiol. 49, e12885 (2023).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1009_CR91","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2011.12.007","volume":"507","author":"Q Lin","year":"2012","unstructured":"Lin, Q. et al. Promoter methylation analysis of seven clock genes in Parkinson\u2019s disease. Neurosci. Lett. 507, 147\u2013150 (2012).","journal-title":"Neurosci. Lett."},{"key":"1009_CR92","doi-asserted-by":"publisher","first-page":"101822","DOI":"10.1016\/j.pneurobio.2020.101822","volume":"192","author":"L Chouliaras","year":"2020","unstructured":"Chouliaras, L. et al. Epigenetic regulation in the pathophysiology of Lewy body dementia. Prog. Neurobiol. 192, 101822 (2020).","journal-title":"Prog. Neurobiol."},{"key":"1009_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neulet.2008.02.041","volume":"435","author":"HC Liu","year":"2008","unstructured":"Liu, H. C., Hu, C. J., Tang, Y. C. & Chang, J. G. A pilot study for circadian gene disturbance in dementia patients. Neurosci. Lett. 435, 229\u2013233 (2008).","journal-title":"Neurosci. Lett."},{"key":"1009_CR94","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12031-011-9520-8","volume":"45","author":"L Gravotta","year":"2011","unstructured":"Gravotta, L., Gavrila, A. M., Hood, S. & Amir, S. Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain. J. Mol. Neurosci. 45, 162\u2013171 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"1009_CR95","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0024-3205(00)00751-7","volume":"67","author":"V Ben","year":"2000","unstructured":"Ben, V. & Bruguerolle, B. Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study. Life Sci. 67, 1549\u20131558 (2000).","journal-title":"Life Sci."},{"key":"1009_CR96","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1096\/fj.201901565RR","volume":"34","author":"WW Liu","year":"2020","unstructured":"Liu, W. W. et al. BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson\u2019s disease mouse model. FASEB J. 34, 6570\u20136581 (2020).","journal-title":"FASEB J."},{"key":"1009_CR97","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1126\/science.1150179","volume":"318","author":"L Yin","year":"2007","unstructured":"Yin, L. et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 318, 1786\u20131789 (2007).","journal-title":"Science"},{"key":"1009_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02494-y","volume":"19","author":"L Kou","year":"2022","unstructured":"Kou, L. et al. The circadian clock protein Rev-erb\u03b1 provides neuroprotection and attenuates neuroinflammation against Parkinson\u2019s disease via the microglial NLRP3 inflammasome. J. Neuroinflammation 19, 133 (2022).","journal-title":"J. Neuroinflammation"},{"key":"1009_CR99","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.cell.2014.03.039","volume":"157","author":"S Chung","year":"2014","unstructured":"Chung, S. et al. Impact of circadian nuclear receptor REV-ERBa on midbrain dopamine production and mood regulation. Cell 157, 858\u2013868 (2014).","journal-title":"Cell"},{"key":"1009_CR100","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s13311-022-01215-w","volume":"19","author":"J Kim","year":"2022","unstructured":"Kim, J. et al. Pharmacological rescue with SR8278, a circadian nuclear receptor REV-ERB\u03b1 antagonist as a therapy for mood disorders in Parkinson\u2019s disease. Neurotherapeutics 19, 592\u2013607 (2022).","journal-title":"Neurotherapeutics"},{"key":"1009_CR101","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1009_CR102","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41531-022-00321-y","volume":"8","author":"M Beckers","year":"2022","unstructured":"Beckers, M., Bloem, B. R. & Verbeek, M. M. Mechanisms of peripheral levodopa resistance in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 56 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1009_CR103","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02257677","volume":"5","author":"E Fertl","year":"1993","unstructured":"Fertl, E., Auff, E., Doppelbauer, A. & Waldhauser, F. Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. J. Neural Transm. Park. Dis. Dement. Sect. 5, 227\u2013234 (1993).","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"1009_CR104","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/07420520500545862","volume":"23","author":"AJ Lewy","year":"2006","unstructured":"Lewy, A. J., Emens, J., Jackman, A. & Yuhas, K. Circadian uses of melatonin in humans. Chronobiol. Int. 23, 403\u2013412 (2006).","journal-title":"Chronobiol. Int."},{"key":"1009_CR105","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.03.029","volume":"75","author":"JH Ahn","year":"2020","unstructured":"Ahn, J. H. et al. Prolonged-release melatonin in Parkinson\u2019s disease patients with a poor sleep quality: a randomized trial. Parkinsonism Relat. Disord. 75, 50\u201354 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1009_CR106","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","volume":"6","author":"GA Dowling","year":"2005","unstructured":"Dowling, G. A. et al. Melatonin for sleep disturbances in Parkinson\u2019s disease. Sleep. Med. 6, 459\u2013466 (2005).","journal-title":"Sleep. Med."},{"key":"1009_CR107","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","volume":"254","author":"CA Medeiros","year":"2007","unstructured":"Medeiros, C. A. et al. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson\u2019s disease. A randomized, double blind, placebo-controlled study. J. Neurol. 254, 459\u2013464 (2007).","journal-title":"J. Neurol."},{"key":"1009_CR108","doi-asserted-by":"publisher","first-page":"110485","DOI":"10.1016\/j.biopha.2020.110485","volume":"129","author":"DL Delgado-Lara","year":"2020","unstructured":"Delgado-Lara, D. L. et al. Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson\u2019s disease. Biomed. Pharmacother. 129, 110485 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"1009_CR109","doi-asserted-by":"publisher","first-page":"784314","DOI":"10.3389\/fnagi.2022.784314","volume":"14","author":"H Ma","year":"2022","unstructured":"Ma, H., Yan, J., Sun, W., Jiang, M. & Zhang, Y. Melatonin treatment for sleep disorders in Parkinson\u2019s disease: a meta-analysis and systematic review. Front. Aging Neurosci. 14, 784314 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1009_CR110","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13311-021-01013-w","volume":"18","author":"M Kaul","year":"2021","unstructured":"Kaul, M., Zee, P. C. & Sahni, A. S. Effects of cannabinoids on sleep and their therapeutic potential for sleep disorders. Neurotherapeutics 18, 217\u2013227 (2021).","journal-title":"Neurotherapeutics"},{"key":"1009_CR111","doi-asserted-by":"publisher","first-page":"15744","DOI":"10.1073\/pnas.0908733106","volume":"106","author":"Y Isojima","year":"2009","unstructured":"Isojima, Y. et al. CKI\u03b5\/\u03b4-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock. Proc. Natl Acad. Sci. USA 106, 15744\u201315749 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR112","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1258\/la.2010.009117","volume":"44","author":"CR Hooijmans","year":"2010","unstructured":"Hooijmans, C. R., Tillema, A., Leenaars, M. & Ritskes-Hoitinga, M. Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Lab Anim. 44, 170\u2013175 (2010).","journal-title":"Lab Anim."},{"key":"1009_CR113","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/0748730420940483","volume":"35","author":"DJ Dijk","year":"2020","unstructured":"Dijk, D. J. & Duffy, J. F. Novel approaches for assessing circadian rhythmicity in humans: a review. J. Biol. Rhythms 35, 421\u2013438 (2020).","journal-title":"J. Biol. Rhythms"},{"key":"1009_CR114","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ncl.2019.05.001","volume":"37","author":"KJ Reid","year":"2019","unstructured":"Reid, K. J. Assessment of circadian rhythms. Neurol. Clin. 37, 505\u2013526 (2019).","journal-title":"Neurol. Clin."},{"key":"1009_CR115","doi-asserted-by":"publisher","first-page":"e000876","DOI":"10.1136\/bmjsem-2020-000876","volume":"7","author":"A Basti","year":"2021","unstructured":"Basti, A. et al. Diurnal variations in the expression of core-clock genes correlate with resting muscle properties and predict fluctuations in exercise performance across the day. BMJ Open Sport Exerc. Med. 7, e000876 (2021).","journal-title":"BMJ Open Sport Exerc. Med."},{"key":"1009_CR116","doi-asserted-by":"publisher","first-page":"1157654","DOI":"10.3389\/fdgth.2023.1157654","volume":"5","author":"B Dose","year":"2023","unstructured":"Dose, B., Yal\u00e7in, M., Dries, S. P. M. & Rel\u00f3gio, A. TimeTeller for timing health: the potential of circadian medicine to improve performance, prevent disease and optimize treatment. Front. Digit. Health 5, 1157654 (2023).","journal-title":"Front. Digit. Health"},{"key":"1009_CR117","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1172\/JCI120874","volume":"128","author":"N Wittenbrink","year":"2018","unstructured":"Wittenbrink, N. et al. High-accuracy determination of internal circadian time from a single blood sample. J. Clin. Invest. 128, 3826\u20133839 (2018).","journal-title":"J. Clin. Invest."},{"key":"1009_CR118","doi-asserted-by":"publisher","first-page":"15643","DOI":"10.1073\/pnas.1003878107","volume":"107","author":"M Akashi","year":"2010","unstructured":"Akashi, M. et al. Noninvasive method for assessing the human circadian clock using hair follicle cells. Proc. Natl Acad. Sci. USA 107, 15643\u201315648 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1009_CR119","doi-asserted-by":"crossref","unstructured":"Nelson, N. et al. Comprehensive integrative analysis of circadian rhythms in human saliva. npj Biol. Timing Sleep 2, 17 (2025).","DOI":"10.1038\/s44323-025-00035-3"},{"key":"1009_CR120","doi-asserted-by":"publisher","first-page":"e0305712","DOI":"10.1371\/journal.pone.0305712","volume":"19","author":"M Yal\u00e7in","year":"2024","unstructured":"Yal\u00e7in, M. et al. Molecular characterization of the circadian clock in patients with Parkinson\u2019s disease-CLOCK4PD study protocol. PLoS ONE19, e0305712 (2024).","journal-title":"PLoS ONE"},{"key":"1009_CR121","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.sleep.2018.01.001","volume":"44","author":"JK Martino","year":"2018","unstructured":"Martino, J. K., Freelance, C. B. & Willis, G. L. The effect of light exposure on insomnia and nocturnal movement in Parkinson\u2019s disease: an open label, retrospective, longitudinal study. Sleep. Med. 44, 24\u201331 (2018).","journal-title":"Sleep. Med."},{"key":"1009_CR122","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamaneurol.2016.5192","volume":"74","author":"A Videnovic","year":"2017","unstructured":"Videnovic, A. et al. Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: a randomized clinical trial. JAMA Neurol. 74, 411\u2013418 (2017).","journal-title":"JAMA Neurol."},{"key":"1009_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1050-z","volume":"16","author":"S Rutten","year":"2016","unstructured":"Rutten, S. et al. A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson\u2019s disease. BMC Psychiatry 16, 355 (2016).","journal-title":"BMC Psychiatry"},{"key":"1009_CR124","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/07420520701420717","volume":"24","author":"GL Willis","year":"2007","unstructured":"Willis, G. L. & Turner, E. J. D. Primary and secondary features of Parkinson\u2019s disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int. 24, 521\u2013537 (2007).","journal-title":"Chronobiol. Int."},{"key":"1009_CR125","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1515\/revneuro-2011-0072","volume":"23","author":"GL Willis","year":"2012","unstructured":"Willis, G. L., Moore, C. & Armstrong, S. M. A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson\u2019s disease. Rev. Neurosci. 23, 199\u2013226 (2012).","journal-title":"Rev. Neurosci."},{"key":"1009_CR126","doi-asserted-by":"publisher","first-page":"e1145","DOI":"10.1212\/WNL.0000000000007090","volume":"92","author":"S Rutten","year":"2019","unstructured":"Rutten, S. et al. Bright light therapy for depression in Parkinson disease. Neurology 92, e1145\u2013e1156 (2019).","journal-title":"Neurology"},{"key":"1009_CR127","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/archpsyc.1996.01830010043007","volume":"53","author":"RW Lam","year":"1996","unstructured":"Lam, R. W. et al. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch. Gen. Psychiatry 53, 41\u201344 (1996).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1009_CR128","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1126\/science.7434030","volume":"210","author":"AJ Lewy","year":"1980","unstructured":"Lewy, A. J., Wehr, T. A., Goodwin, F. K., Newsome, D. A. & Markey, S. P. Light suppresses melatonin secretion in humans. Science 210, 1267\u20131269 (1980).","journal-title":"Science"},{"key":"1009_CR129","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/mds.21542","volume":"22","author":"S Paus","year":"2007","unstructured":"Paus, S. et al. Bright light therapy in Parkinson\u2019s disease: a pilot study. Mov. Disord. 22, 1495\u20131498 (2007).","journal-title":"Mov. Disord."},{"key":"1009_CR130","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1037\/amp0001218","volume":"79","author":"G Chen","year":"2024","unstructured":"Chen, G. et al. Increased functional connectivity between the midbrain and frontal cortex following bright light therapy in subthreshold depression: a randomized clinical trial. Am. Psychol. 79, 437\u2013450 (2024).","journal-title":"Am. Psychol."},{"key":"1009_CR131","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1017\/S1092852900019611","volume":"10","author":"M Terman","year":"2005","unstructured":"Terman, M. & Terman, J. S. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 10, 647\u2013663 (2005).","journal-title":"CNS Spectr."},{"key":"1009_CR132","doi-asserted-by":"publisher","first-page":"102474","DOI":"10.1016\/j.eclinm.2024.102474","volume":"69","author":"B Feigl","year":"2024","unstructured":"Feigl, B. et al. Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson\u2019s disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial. EClinicalMedicine 69, 102474 (2024).","journal-title":"EClinicalMedicine"},{"key":"1009_CR133","doi-asserted-by":"publisher","first-page":"117345","DOI":"10.1016\/j.lfs.2020.117345","volume":"245","author":"YS Feng","year":"2020","unstructured":"Feng, Y. S. et al. The benefits and mechanisms of exercise training for Parkinson\u2019s disease. Life Sci. 245, 117345 (2020).","journal-title":"Life Sci."},{"key":"1009_CR134","doi-asserted-by":"publisher","first-page":"101384","DOI":"10.1016\/j.smrv.2020.101384","volume":"55","author":"J Cristini","year":"2021","unstructured":"Cristini, J. et al. The effects of exercise on sleep quality in persons with Parkinson\u2019s disease: a systematic review with meta-analysis. Sleep. Med. Rev. 55, 101384 (2021).","journal-title":"Sleep. Med. Rev."},{"key":"1009_CR135","doi-asserted-by":"crossref","unstructured":"Curtis, W. M., Seeds, W. A., Mattson, M. P. & Bradshaw, P. C. NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of Parkinson\u2019s disease. Cells 11, 2416 (2022).","DOI":"10.3390\/cells11152416"},{"key":"1009_CR136","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cophys.2019.04.020","volume":"10","author":"CA Wolff","year":"2019","unstructured":"Wolff, C. A. & Esser, K. A. Exercise timing and circadian rhythms. Curr. Opin. Physiol. 10, 64\u201369 (2019).","journal-title":"Curr. Opin. Physiol."},{"key":"1009_CR137","first-page":"600","volume":"10","author":"W Teo","year":"2011","unstructured":"Teo, W., Newton, M. J. & McGuigan, M. R. Circadian rhythms in exercise performance: implications for hormonal and muscular adaptation. J. Sports Sci. Med. 10, 600\u2013606 (2011).","journal-title":"J. Sports Sci. Med."},{"key":"1009_CR138","doi-asserted-by":"publisher","first-page":"1282357","DOI":"10.3389\/fphar.2023.1282357","volume":"14","author":"B Shen","year":"2023","unstructured":"Shen, B. et al. Effects of exercise on circadian rhythms in humans. Front. Pharm. 14, 1282357 (2023).","journal-title":"Front. Pharm."},{"key":"1009_CR139","doi-asserted-by":"publisher","first-page":"4","DOI":"10.17712\/nsj.2023.1.20220105","volume":"28","author":"MA Almikhlafi","year":"2023","unstructured":"Almikhlafi, M. A. The role of exercise in Parkinson\u2019s disease. Neuroscience28, 4\u201312 (2023).","journal-title":"Neuroscience"},{"key":"1009_CR140","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.smhs.2022.11.003","volume":"5","author":"HK Kim","year":"2023","unstructured":"Kim, H. K., Radak, Z., Takahashi, M., Inami, T. & Shibata, S. Chrono-exercise: Time-of-day-dependent physiological responses to exercise. Sports Med. Health Sci. 5, 50\u201358 (2023).","journal-title":"Sports Med. Health Sci."},{"key":"1009_CR141","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/JPD-160791","volume":"6","author":"SS Paul","year":"2016","unstructured":"Paul, S. S. et al. Obtaining reliable estimates of ambulatory physical activity in people with Parkinson\u2019s disease. J. Parkinsons Dis. 6, 301\u2013305 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"1009_CR142","doi-asserted-by":"publisher","unstructured":"Nagaki, K., Fujioka, S., Sasai, H., Yamaguchi, Y. & Tsuboi, Y. Physical activity and its diurnal fluctuations vary by non-motor symptoms in patients with Parkinson\u2019s disease: an exploratory study. Healthcare https:\/\/doi.org\/10.3390\/healthcare10040749 (2022).","DOI":"10.3390\/healthcare10040749"},{"key":"1009_CR143","doi-asserted-by":"publisher","unstructured":"Su, H. C., Sun, Y. T., Yang, M. Y., Wu, C. Y. & Hsu, C. M. Dihydroisotanshinone I and BMAL-SIRT1 pathway in an in vitro 6-OHDA-induced model of Parkinson\u2019s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241311088 (2023).","DOI":"10.3390\/ijms241311088"},{"key":"1009_CR144","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.expneurol.2011.08.003","volume":"232","author":"T Kudo","year":"2011","unstructured":"Kudo, T., Loh, D. H., Truong, D., Wu, Y. & Colwell, C. S. Circadian dysfunction in a mouse model of Parkinson\u2019s disease. Exp. Neurol. 232, 66\u201375 (2011).","journal-title":"Exp. Neurol."},{"key":"1009_CR145","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2014.08.024","volume":"71","author":"K Fifel","year":"2014","unstructured":"Fifel, K. & Cooper, H. M. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson\u2019s disease. Neurobiol. Dis. 71, 359\u2013369 (2014).","journal-title":"Neurobiol. Dis."},{"key":"1009_CR146","first-page":"742","volume":"41","author":"J Kim","year":"2018","unstructured":"Kim, J. et al. Abrogation of the circadian nuclear receptor REV-ERB\u03b1 exacerbates 6-hydroxydopamine-induced dopaminergic neurodegeneration. Mol. Cells 41, 742\u2013752 (2018).","journal-title":"Mol. Cells"},{"key":"1009_CR147","doi-asserted-by":"publisher","first-page":"112539","DOI":"10.1016\/j.bbr.2020.112539","volume":"383","author":"Q Liu","year":"2020","unstructured":"Liu, Q. et al. Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 inflammasome in MPTP-induced Parkinson disease in mice. Behav. Brain Res. 383, 112539 (2020).","journal-title":"Behav. Brain Res."},{"key":"1009_CR148","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12640-022-00633-0","volume":"41","author":"JY Liu","year":"2023","unstructured":"Liu, J. Y., Xue, J., Wang, F., Wang, Y. L. & Dong, W. L. alpha-Synuclein-induced destabilized BMAL1 mRNA leads to circadian rhythm disruption in Parkinson\u2019s disease. Neurotox. Res. 41, 177\u2013186 (2023).","journal-title":"Neurotox. Res."},{"key":"1009_CR149","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jare.2021.01.006","volume":"31","author":"EA Abdel-Rahman","year":"2021","unstructured":"Abdel-Rahman, E. A. et al. Sleep\/wake calcium dynamics, respiratory function, and ROS production in cardiac mitochondria. J. Adv. Res. 31, 35\u201347 (2021).","journal-title":"J. Adv. Res."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01009-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01009-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01009-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:41:14Z","timestamp":1757241674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01009-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":149,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01009-9","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R. is CEO of TimeTeller GmbH and has granted and pending patents regarding the characterisation of circadian rhythms for different applications. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}